No evidence for vasculogenesis regulation by angiostatin during mouse embryonic stem cell differentiation

Journal of Cellular Physiology

Volumn 213, Issue 1, 2007, Pages 27-35

  Prandini, Marie Hélène ^a,b   Desroches Castan, Agnès ^a,b   Feraud, Olivier ^a,b,c   Vittet, Daniel ^a,b  

^a INSERM   (France)

^b CEA GRENOBLE   (France)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; ANGIOMOTIN; ANGIOSTATIN; CD31 ANTIGEN; COLLAGEN TYPE 1; GENE PRODUCT; PLASMINOGEN; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; GEL; IN VITRO STUDY; MESODERM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOSTATINS; ANIMALS; BASE SEQUENCE; BINDING SITES; BLOOD VESSELS; CELL DIFFERENTIATION; CELL LINE; DNA PRIMERS; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34548507210     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21084     Document Type: Article

References (52)

1. Asahara T, Kawamoto A. 2004. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287:C572-C579.
2. Bautch VL, Redick SD, Scalia A, Harmaty M, Carmeliet P, Rapoport R. 2000. Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A. Blood 95:1979-1987.
3. Birchmeier C, Gherardi E. 1998. Developmental roles of HGF/5F and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8:404-410.
4. Cao Y, Xue L. 2004. Angiostatin. Semin Thromb Hemost 30:83-93.
5. Capillo M, Mancuso P, Gobbi A, Monestiroli S, Pruneri G, Dell'Agnola C, Martinelli G, Shultz L, Bertolini F. 2003. Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors. Clin Cancer Res 9:377-382.
6. Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395.
7. Chen YH, Wu HL, Chen CK, Huang YH, Yang BC, Wu LW. 2003. Angiostatin antagonizes the action of VEGF-A in human endothelial cells via two distinct pathways. Biochem Biophys Res Commun 310:804-810.
8. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. 1998. A common precursor for hematopoietic and endothelial cells. Development 125:725-732.
9. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY. 1984. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229.
10. Eriksson K, Magnusson P, Dixelius J, Claesson-Welsh L, Cross MJ. 2003. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways. FEBS Lett 536:19-24.
11. Fehling HJ, Lacaud G, Kubo A, Kennedy M, Robertson S, Keller G, Kouskoff V. 2003. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130:4217-4227.
12. Feraud O, Vittet D. 2003. Murine embryonic stem cell in vitro differentiation: Applications to the study of vascular development. Histol Histopathol 18:191-199.
13. Feraud O, Cao Y, Vittet D. 2001. Embryonic stem cell-derived embryoid bodies development in collagen gels recapitulates sprouting angiogenesis. Lab Invest 81:1669-1681.
14. Feraud O, Prandini MH, Vittet D. 2003. Vasculogenesis and angiogenesis from in vitro differentiation of mouse embryonic stem cells. Methods Enzymol 365:214-228.
15. Finlay TH, Katz J, Kirsch L, Levitz M, Nathoo SA, Seiler S. 1983. Estrogen-stimulated uptake of plasminogen by the mouse uterus. Endocrinology 112:856-861.
16. Flamme I, Frolich T, Risau W. 1997. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173:206-210.
17. Geiger JH, Cnudde SE. 2004. What the structure of angiostatin may tell us about its mechanism of action. J Thromb Haemost 2:23-34.
18. Guan K, Czyz J, Furst DO, Wobus AM. 2001. Expression and cellular distribution of alpha(v)integrins in beta(I)integrin-deficient embryonic stem cell-derived cardiac cells. J Mol Cell Cardiol 33:521-532.
19. Hirsch E, Gullberg D, Balzac F, Altruda F, Silengo L, Tarone G. 1994. Alpha v integrin subunit is predominantly located in nervous tissue and skeletal muscle during mouse development. Dev Dyn 201:108-120.
20. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB. 2004. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288-293.
21. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC. 2004. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752-2760.
22. Ito H, Rovira II, Bloom ML, Takeda K, Ferrans VJ, Quyyumi AA, Finkel T. 1999. Endothelial progenitor cells as putative targets for angiostatin. Cancer Res 59:5875-5877.
23. Keller G. 2005. Embryonic stem cell differentiation: Emergence of a new era in biology and medicine. Genes Dev 19:1129-1155.
24. Lannutti BJ, Gately ST, Quevedo ME, Soff GA, Paller AS. 1997. Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo. Cancer Res 57:5277-5280.
25. Li ZJ, Wang ZZ, Zheng YZ, Xu B, Yang RC, Scadden DT, Han ZC. 2005. Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) during embryonic stem cell differentiation. J Cell Biochem 95:559-570.
26. Ling V, Neben S. 1997. In vitro differentiation of embryonic stem cells: Immunophenotypic analysis of cultured embryoid bodies. J Cell Physiol 171:104-115.
27. Lucas R, Holmgren L, Garcia I, Jimenez B, Mandriota SJ, Borlat F, Sim BK, Wu Z, Grau GE, Shing Y, Soff GA, Bouck N, Pepper MS. 1998. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 92:4730-4741.
28. Magnusson P, Rolny C, Jakobsson L, Wikner C, Wu Y, Hicklin DJ, Claesson-Weish L. 2004. Deregulation of Flk-1/vascular endothelial growth factor receptor-2 in fibroblast growth factor receptor-1-deficient vascular stem cell development. J Cell Sci 117:1513-1523.
29. Marchetti S, Gimond C, Iljin K, Bourcier C, Alitalo K, Pouyssegur J, Pages G. 2002. Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. J Cell Sci 115:2075-2085.
30. Murasawa S, Asahara T. 2005. Endothelial progenitor cells for vasculogenesis. Physiology (Bethesda) 20:36-42.
31. Nishikawa SI, Nishikawa S, Hirashima M, Matsuyoshi N, Kodama H. 1998. Progressive lineage analysis by cell sorting and culture identifies FLK1 + VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 125:1747-1757.
32. Nyberg P, Xie L, Kalluri R. 2005. Endogenous inhibitors of angiogenesis. Cancer Res 65:3967-3979.
33. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. 1994. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328.
34. Park C, Ma YD, Choi K. 2005. Evidence for the hemangioblast. Exp Hematol 33:965-970.
35. Redick SD, Bautch VL. 1999. Developmental platelet endothelial cell adhesion molecule expression suggests multiple roles for a vascular adhesion molecule. Am J Pathol 154:1137-1147.
36. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
37. Robertson SM, Kennedy M, Shannon JM, Keller G. 2000. A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development 127:2447-2459.
38. Schmidt A, Wenzel D, Ferring I, Kazemi S, Sasaki T, Hescheler J, Timpl R, Addicks K, Fleischmann BK, Bloch W. 2004. Influence of endostatin on embryonic vasculo- and angiogenesis. Dev Dyn 230:468-480.
39. Schuch G, Heymach JV, Nomi M, Machluf M, Force J, Atala A, Eder JPJr, Folkman J, Soker S. 2003. Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res 63:8345-8350.
40. Shimono A, Behringer RR. 2003. Angiomotin regulates visceral endoderm movements during mouse embryogenesis. Curr Biol 13:613-617.
41. Sim BK, O'Reilly MS, Liang H, Fortier AH, He W, Madsen JW, Lapcevich R, Nacy CA. 1997. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 57:1329-1334.
42. Soff GA, Wang H, Cundiff DL, Jiang K, Martone B, Rademaker AW, Doll JA, Kuzel TM. 2005. In vivo generation of angiostatin isoforms by administration of a plasminogen activator and a free sulfhydryl donor: A phase I study of an angiostatic cocktail of tissue plasminogen activator and mesna. Clin Cancer Res 11:6218-6225.
43. Swiatek PJ, Gridley T. 1993. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev 7:2071-2084.
44. Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L. 2001. Angiomotin: An angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 152:1247-1254.
45. Urbich C, Dimmeler S. 2004. Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res 95:343-353.
46. Vecchi A, Garlanda C, Lampugnani MG, Resnati M, Matteucci C, Stoppacciaro A, Schnurch H, Risau W, Ruco L, Mantovani A, et al. 1994. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur J Cell Biol 63:247-254.
47. Vittet D, Prandini MH, Berthier R, Schweitzer A, Martin-Sisteron H, Uzan G, Dejana E. 1996. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 88:3424-3431.
48. Vu TH, Werb Z. 2000. Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev 14:2123-2133.
49. Wajih N, Sane DC. 2003. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells. Blood 101:1857-1863.
50. Wartenberg M, Gunther J, Hescheler J, Sauer H. 1998. The embryoid body as a novel in vitro assay system for antiangiogenic agents. Lab Invest 78:1301-1314.
51. Welm B, Mott J, Werb Z. 2002. Developmental biology: Vasculogenesis is a wreck without RECK. Curr Biol 12:R209-R211.
52. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K, Nishikawa S. 2000. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.